Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.73M Buy
12,991
+1,064
+9% +$131K 0.06% 184
2023
Q3
$1.35M Sell
11,927
-709
-6% -$87.3K 0.05% 190
2023
Q2
$1.59M Buy
12,636
+9,736
+336% +$1.15M 0.06% 181
2023
Q1
$328K Sell
2,900
-316
-10% -$34.8K 0.01% 308
2022
Q4
$325K Buy
3,216
+316
+11% +$31.5K 0.01% 299
2022
Q3
$271K Sell
2,900
-21,267
-88% -$2.17M 0.01% 310
2022
Q2
$2.15M Buy
24,167
+18,788
+349% +$1.82M 0.1% 136
2022
Q1
$545K Buy
5,379
+1,658
+45% +$168K 0.02% 235
2021
Q4
$386K Sell
3,721
-270
-7% -$27.9K 0.02% 276
2021
Q3
$433K Buy
3,991
+203
+5% +$22.7K 0.02% 270
2021
Q2
$405K Sell
3,788
-130
-3% -$15.1K 0.02% 272
2021
Q1
$466K Buy
3,918
+1,600
+69% +$184K 0.02% 231
2020
Q4
$264K Buy
2,318
+230
+11% +$24.8K 0.02% 261
2020
Q3
$215K Hold
2,088
0.02% 224
2020
Q2
$204K Buy
+2,088
New +$210K 0.02% 231
2020
Q1
Sell
-2,181
Closed -$252K 231
2019
Q4
$252K Hold
2,181
0.02% 211
2019
Q3
$226K Buy
+2,181
New +$223K 0.02% 209
2019
Q2
Sell
-2,391
Closed -$211K 237
2019
Q1
$211K Buy
+2,391
New +$197K 0.02% 216

Other funds holding FISV

GW & Wade's FISV Position: Q4 2023 in Review

GW & Wade increased its Fiserv Inc (FISV) stake by 8.9% in Q4 2023, buying an estimated $131K and bringing the position to 12,991 shares worth $1.73M. The position accounts for 0.06% of the portfolio, ranked #184.

GW & Wade first reported a position in FISV in Q1 2019 and has held it in 18 quarters since. The position peaked at $2.15M in Q2 2022. 1,590 funds tracked by Wall St. Rank hold FISV as of Q4 2023.

  • GW & Wade held 12,991 shares of Fiserv Inc worth $1.73M as of Q4 2023.
  • GW & Wade bought 1,064 Fiserv Inc shares in Q4 2023, an estimated $131K.
  • Fiserv Inc made up 0.06% of GW & Wade's portfolio in Q4 2023, its #184 holding.
  • GW & Wade first reported a position in Fiserv Inc in Q1 2019 and has held it in 18 quarters since.
  • GW & Wade's Fiserv Inc position peaked at $2.15M in Q2 2022.
  • 1,590 funds tracked by Wall St. Rank held Fiserv Inc as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.